Skip to content

Research Forensic Library

A program of the Global Forensic and Justice Center at Florida International University

Research Forensic Library

A program of the Global Forensic and Justice Center at Florida International University

  • Home
  • About
  • Browse by category
    • Alcohol
    • Anthropology
    • Biometrics
    • Bloodstain Pattern Analysis
    • Cannabis and Cannabinoids
    • Chemistry
    • Crime Scene Investigation and Reconstruction
    • Criminal Justice System
    • Digital and Multimedia Analysis
    • DNA and Biology
    • DREs / Traffic Safety Resource Prosecutors
    • Entomology
    • Fingerprints / Friction Ridge
    • Fire Investigations and Explosions
    • Firearms and Toolmarks
    • Footwear and Tire
    • Forensic Pathology and Medicolegal Death Investigation
    • Genetic Genealogy
    • Laboratory Operations
    • Odontology
    • Photography, Video, and Imaging Technology
    • Questioned Documents
    • Seized Drugs / Controlled Substances
    • Sexual Assault / SANE
    • Statistics and Data Analysis
    • Toxicology
    • Trace Evidence
    • Veterinary Forensics
    • Wildlife
  • Browse by collection
    • ANSI/ASB Standards
    • CFSRE
    • DEA
    • EMCDDA
    • Historical
    • INCB
    • Journals
    • MMWR
    • NAP
    • NHTSA
    • NIJ
    • NIST
    • OSAC
    • UNODC
  • Search Everything
  • forensiclib@fiu.edu

Center for Forensic Science Research & Education

TitleAuthorsSourceLinkYear
Evaluation of Xylazine Test Strips (BTNX) for Drug Checking PurposesKrotulski, AJ; Shinefeld, J; DeBord, J; Teixeira da Silva, D; Logan, BK.CFSRE; 2023www.cfsre.org/nps-discovery/drug-checking/evaluation-of-xylazine-test-strips-btnx-for-drug-checking-purposes2023
Recommended Scope for NPS Testing in the United States: Q1 2023Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefson, Elisa Shoff, Szabolcs Sofalvi, Svanto Vikingsson, Michael Truver, Celia Modoll, and Barry LoganSOFT, CFSRE; February 2023www.cfsre.org/nps-discovery/scope-recommendations2023
N-Desethyl IsotonitazeneAlex J. Krotulski, PhD; Reta Newman, MA; Michael Gilbert, BS; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFTCFSRE; December 20, 2022www.cfsre.org/nps-discovery/monographs2022
Drug Checking Quarterly Report – Q3 2022Alex J. Krotulski, PhD; Jen Shinefeld, MS; Joshua DeBord, PhD; Daniel Teixeira da Silva, MD; and Barry K. Logan, PhD, F-ABFTCFSRE, PDPH; November 2022www.cfsre.org/nps-discovery/drug-checking/drug-checking-q3-2022-philadelphia-pennsylvania-usa2022
ToxIC Fentalog Study Group – Quarterly NPS Report – Q3Alex Manini, MD; Alex J Krotulski, PhD; Sara E. Walton, MS; Paul Wax, MD; Jeffery Brent, MD, PhD; Kim Aldy, DO; Alexandra Amaducci, DO; Dlane Calello, MD; Adrienne Hughes, MD; Anthony Pizon, MD; Michael Levine, MD; Evan Schwarz, MD; Bryan Judge, MD; and Barry K. Logan, PhD, F-ABFTCSFRE; TIC; ACMT; October 2022www.cfsre.org/nps-discovery/clinical-reports2022
NPS Discovery Toolkit: N-Pyrrolidino EtonitazeneSara E. Walton, MS; Alex J. Krotulski, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Donna M. Papsun, MS, D-ABFT; and Barry K. Logan, PhD, F-ABFTCFSRE; October 2022www.cfsre.org/nps-discovery/analytical-toolkits2022
NPS Benzodiazepines in the United States – Q3 Trend ReportAlex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFTCFSRE; October 2022www.cfsre.org/nps-discovery/trend-reports/nps-benzodiazepines/report/49?trend_type_id=12022
Fentanyl Purity, Potency, & Synthesis: Real-Time Testing of Opioid Drug Products in the United StatesKrotulski, AJ, Shinefeld, J, DeBord, J, Logan, BKCFSRE; August, 2022www.npsdiscovery.org/fentanyl-purity-potency-synthesis-real-time-testing-of-opioid-drug-products-in-the-united-states/2022
Recommended Scope for NPS Testing in the United States: Q2 2022Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Kevin Shanks, Szabolcs Sofalvi, Wayne Lewallen, Svante Vikingsson, and Barry LoganCFSRE; July 2022www.npsdiscovery.org/reports/nps-scope-recommendations/2022
N-Propyl ButyloneAlex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Melissa F. Fogarty, MSFS, D-ABFTFT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCFSRE; July 21, 2022www.npsdiscovery.org/reports/monographs/2022
NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens, and Synthetic Cannabinoids – Q2 2022 Trend ReportsAlex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFTCFSRE; July 13, 2022www.npsdiscovery.org/reports/trend-reports/2022
CH-FUBIATAAlex J. Krotulski, PhD; Jennifer Shinefeld, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Joshua DeBord, PhD; and Barry K. Logan, PhD, F-ABFTCFSRE; June 21, 2022www.npsdiscovery.org/reports/monographs/2022
Bromazolam Prevalence Surging Across the United States Driven In Part by Increasing Detections Alongside FentanylDonna M. Papsun, MS, D-ABFT-FT; Alex J. Krotulski, PhD; Rebecca Mastrovito, MS; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCFSRE; June 15, CFSRE; June 15, 2022www.npsdiscovery.org/bromazolam-prevalence-surging-across-the-united-states-driven-in-part-by-increasing-detections-alongside-fentanyl/2022
N-Cyclohexyl ButyloneAlex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Ryan Farrell; Zackery Roberson, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCFSRE; June 9, 2022www.npsdiscovery.org/reports/monographs/2022
Drug Checking (Q2 2022): Philadelphia, Pennsylvania, USAAlex J. Krotulski, PhD; Jen Shinefeld, MS; Jeffrey Hom, MD, MPH; Sara E. Walton, BS; Joshua DeBord, PhD; Barry K. Logan, PhD, F-ABFTCFSRE; June 7, 2022www.npsdiscovery.org/drug-checking-q2-2022-philadelphia-pennsylvania-usa/2021
ADB-5’Br-BINACAAlex J. Krotulski, PhD; Jennifer Shinefeld, MS; Robert M. Schelkun, MS; Donna M. Iula, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Joshua DeBord, PhD; and Barry K. Logan, PhD, F-ABFTCFSRE; May 26, 2022www.npsdiscovery.org/wp-content/uploads/2022/05/ADB-5Br-BINACA_055622_CFSRE-Chemistry_Report.pdf2022
BZO-4en-POXIZIDAlex J. Krotulski, PhD; Ryan Farrell; Armando Vargas; Melissa F. Fogarty, MSFS, DABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFCFSRE; May 19, 2022www.npsdiscovery.org/reports/monographs/2022
Recommended Scope for NPS Testing in the United States – Q1 2022Alex Krotulski, Donna Papsun, Dani Mata, Kayla Ellefsen, Elisa Shoff, Kevin Shanks, Szabolcs Sofalvi, Wayne Lewallen, Svante Vikingsson, and Barry LoganCFSRE; May 12, 2022www.npsdiscovery.org/reports/nps-scope-recommendations/2022
N-Cyclohexyl MethyloneAlex J. Krotulski, PhD; Vanquilla Shellman Francis, PhD; Ryan Farrell; Kaitlin Schilde, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCFSRE; May 9, 2022www.npsdiscovery.org/wp-content/uploads/2022/05/N-Cyclohexyl-Methylone_050922_CFSRE-Chemistry_Report.pdf2022
ADB-5Br-INACAAlex J. Krotulski, PhD; Ryan Farrell; Zackery Roberson, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCFSRE; May 17, 2022www.npsdiscovery.org/wp-content/uploads/2022/05/ADB-5Br-INACA_051721_CFSRE-Chemistry_Report.pdf2022
MDMB-5Br-INACAAlex J. Krotulski, PhD; Ryan Farrell; Kaitlin Schilde, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCFSRE; May 17, 2022www.npsdiscovery.org/wp-content/uploads/2022/05/MDMB-5Br-INACA_051721_CFSRE-Chemistry_Report.pdf2022
CH-PIATAAlex J. Krotulski, PhD; Ryan Farrell; Amanda Mohaupt, MSFS; Melissa F. Fogarty, MSFS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCFSRE; April 29, 2022www.npsdiscovery.org/wp-content/uploads/2022/04/CH-PIATA_042922_CFSRE-Chemistry_Report.pdf2021
Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replaces Eutylone in Drug Supply Typically Sold as “Ecstasy” or “Molly”Alex J. Krotulski, PhD; Melissa F. Fogarty, MS, D-ABFT-FT; Donna M. Papsun, MS, D-ABFT-FT; Michael Lamb, MS, D-ABFT-FT; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCFSRE; April 2022www.npsdiscovery.org/reports/public-health-alerts/2022
Synthetic Cannabinoids in the United States: Trend Report: Q1, 2022Alex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFTCFSRE; April 2022www.npsdiscovery.org/reports/trend-reports/2022
Drug Checking Report – Q1 2022: Philadelphia, Pennsylvania, USAAlex J. Krotulski, PhD; Jen Shinefeld, MS; Jeffrey Hom, MD, MPH; Sara E. Walton, MS; and Barry K. Logan, PhD, F-ABFTCSFRE; March 22, 2022www.npsdiscovery.org/reports/drug-checking/2022
N,N-DimethylpentyloneAlex J. Krotulski, PhD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, DABFT- FT; Donna M. Papsun, MS, D-ABFT; Barry K. Logan, PhD, F-ABFTCenter for Forensic Science Research and Education; December 17, 2021www.npsdiscovery.org/wp-content/uploads/2021/12/NN-Dimethylpentylone_121721_CFSRE-Toxicology_Report.pdf2021
Adverse Effects Linked to Next Generation Opioids Reported in Patients Presenting to Emergency Departments After Suspected Opioid OverdoseAlex Manini, MD; Alex J. Krotulski, PhD; Sara E. Walton, MS; Paul Wax, MD; Jeffery Brent, MD, PhD; Kim Aldy, DO; Diane Calello, MD; Alexandra Amaducci, DO; Evan Schwarz, MD; Bryan Judge, MD; Michael Levine, MD; Barry K. Logan, PhD, F-ABFTCenter for Forensic Science Research and Education; December 3, 2021www.npsdiscovery.org/adverse-effects-linked-to-next-generation-opioids-reported-in-patients-presenting-to-emergency-departments-after-suspected-opioid-overdose/2021
N-Piperidinyl EtonitazeneAlex J. Krotulski, PhD; Alex Manini, MD; Diane Calello, MD; Jeff Brent, MD, PhD; Paul Wax, MD; Kim Aldy, MD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFTCenter for Forensic Science Research and Education; November 22, 2021www.npsdiscovery.org/wp-content/uploads/2021/11/N-Piperidinyl-Etonitazene_112221_ToxicologyAnalyticalReport.pdf2021
ADB-PHETINACAAlex J. Krotulski, PhD; Alex Manini, MD; Diane Calello, MD; Jeff Brent, MD, PhD; Paul Wax, MD; Kim Aldy, MD; Sara E. Walton, MS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFTCenter for Forensic Science Research and Education; November 19, 2021www.npsdiscovery.org/wp-content/uploads/2021/11/ADB-PHETINACA_111921_ToxicologyAnalyticalReport.pdf2021
BZO-CHMOXIZIDAlex J. Krotulski, PhD; Ryan Farrell; Amanda Mohaupt; Melissa F. Fogarty, MSFS, DABFT- FT; and Barry K. Logan, PhD, F-ABFTNPS Discovery Center for Forensic Science Research and Education; November 18, 2021www.npsdiscovery.org/wp-content/uploads/2021/11/BZO-CHMOXIZID_111821_CFSRE-Chemistry_Report.pdf2021
ADB-FUBIATAAlex J. Krotulski, PhD; Ryan Farrell; Kaitlin Schilde; Robert M. Schelkun, MS; Donna M. Iula, PhD; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFTCenter for Forensic Science Research and Education; November 17, 2021www.npsdiscovery.org/wp-content/uploads/2021/11/ADB-FUBIATA_111721_CFSRE-Chemistry_Report.pdf2021
BZO-HEXOXIZIDAlex J. Krotulski, PhD; Ryan Farrell; Zackery Roberson; Armando Vargas; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFTCenter for Forensic Science Research and Education; October 19, 2021www.npsdiscovery.org/wp-content/uploads/2021/10/BZO-HEXOXIZID_101921_CFSRE-Chemistry_Report.pdf2021
5F-BZO-POXIZIDAlex J. Krotulski, PhD; Reta Newman, MA; Michael Gilbert, BS; Melissa F. Fogarty, MSFS, D-ABFT-FT; and Barry K. Logan, PhD, F-ABFCenter for Forensic Science Research and Education; October 19, 2021www.npsdiscovery.org/wp-content/uploads/2021/10/5F-BZO-POXIZID_101921_CFSRE-Chemistry_Report.pdf2021
Synthetic Cannabinoids in the United StatesAlex J. Krotulski, PhD; Sara E. Walton, MS; Amanda L.A. Mohr, MSFS, D-ABFT-FT; Barry K. Logan, PhD, F-ABFTCenter for Forensic Science Research and Education; October 13, 2021www.npsdiscovery.org/wp-content/uploads/2021/10/2021-Q3_Synthetic-Cannabinoids_Trend-Report.pdf2021
FluclotizolamAlex J. Krotulski, PhD; Sara E. Walton, MS; Donna M. Papsun, MS, D-ABFT-FT; Melissa F. Fogarty, MSFS, D-ABFT-FT; Barry K. Logan, PhD, F-ABFTCSFRE; November 5www.npsdiscovery.org/reports/monographs/2021
Recommended Scope for NPS Testing in the United States: Q3 2021A Krotulski, D Papsun, D Mata, K Ellefsen, E Shoff, K Shanks, S Sofalvi, S Kacinko, W Lewallen, S Vikingsson, B LoganCFSRE; Quarter 3, Novemberwww.npsdiscovery.org/reports/nps-scope-recommendations/2021
Drug Supply Assessment: Q3 2021 – Philadelphia, PennsylvaniaAlex J. Krotulski, PhD; Jen Shinefeld, MS; et alCenter for Forensic Science Research and Education; October 2021www.npsdiscovery.org/drug-supply-assessment-q3-2021-philadelphia-pennsylvania-usa/2021
MetodesnitazeneAlex J. Krotulski, PhD; Matthew Juhascik, PhD, F-ABFT et alThe Center for Forensic Science Research and Education; September 2021t.co/YUsxge5hEy?amp=12021
New Systematic Naming for Synthetic Cannabinoid “MDA-19” and Its Related Analogues: BZO-HEXOXIZID, 5F-BZO-POXIZID, and BZO-POXIZIDRM Schelkun, MS; AJ Krotulski, PhD; DM Iula, PhD; BK Logan, PhD, F-ABFTCFSRE; Cayman Chemical; NPS Discovery; August 31, 2021www.npsdiscovery.org/wp-content/uploads/2021/08/New-Systematic-Naming-for-MDA-19-and-Related-Analogues_NPS-Discovery_083121.pdf2021
Global Forensic and Justice Center

11200 SW 8th Street
Miami, FL 33199
Contact Us

Explore FIU

About FIU
Admissions
Academics
Locations
Research
Student Life
Athletics
Alumni and Giving
Careers at FIU

Tools & Resources

Phonebook (Directory)
University Calendar
Campus Maps
MyFIU
Canvas
Student Email
Faculty/Staff Email
System Status
Reserve Space
Nondiscrimination and Title IX

Connect

Contact FIU
FIU News

© 2022 Florida International University | Web/Accessibility | Website Feedback |

Powered by PressBook WordPress theme